FDA Tells High Court Warning Letters Aren't Final Actions

Law360, New York (September 19, 2012, 8:45 PM EDT) -- The U.S. Food and Drug Administration argued to the U.S. Supreme Court last week that its warning letters do not constitute final agency actions subject to review in court, urging it to reject holistic health remedy advocates' challenge to letters received by ear candle companies.

The Holistic Candlers and Consumer Association and others filed a petition with the high court in June, saying the D.C. Circuit incorrectly ruled in January that FDA warning letters issued to ear candle makers were not subject to judicial review under...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.